Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/22/21
End: 01/31/29
Due: 01/31/30
Phase: N/A
Priority: Normal
Start: 01/22/21
End: 11/30/23
Due: 11/30/24
Phase: N/A
Priority: Normal
Start: 12/15/20
End: 02/11/22
Due: 02/11/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL) | NCT05218668 | Woolsey Pharmaceuticals | user2@example.com | None | 2021-12-22 | 2029-01-31 | 2030-01-31 | - | - | 2025-07-14 |
| Rho Kinase (ROCK) Inhibitor in Tauopathies - 1 | NCT04734379 | Woolsey Pharmaceuticals | user2@example.com | None | 2021-01-22 | 2023-11-30 | 2024-11-30 | - | - | 2025-07-14 |
| Fasudil fOr redUcing elopemeNt and Spatial Disorientation | NCT04793659 | Woolsey Pharmaceuticals | user2@example.com | None | 2020-12-15 | 2022-02-11 | 2023-02-11 | - | - | 2025-07-14 |